Commonwealth Equity Services’s Candel Therapeutics CADL Stock Holding History

Commonwealth Equity Services’s Portfolio CADL Stock Details CADL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.21M	Sell	115,551 -324	-0.3%	-$3.59K	﹤0.01%	2512
2026 Q2	$1.19M	Buy	115,875 +20,480	+21%	+$155K	﹤0.01%	2581
2026 Q1	$467K	Buy	95,395 +13,049	+16%	+$71K	﹤0.01%	3270
2025 Q4	$465K	Buy	82,346 +125	+0.2%	+$672	﹤0.01%	3225
2025 Q3	$419K	Buy	82,221 +620	+0.8%	+$3.58K	﹤0.01%	3334
2025 Q2	$413K	Buy	81,601 +16,529	+25%	+$85.1K	﹤0.01%	3318
2025 Q1	$368K	Buy	65,072 +23,974	+58%	+$196K	﹤0.01%	3302
2024 Q4	$357K	Buy	+41,098	New	+$243K	﹤0.01%	3257
2024 Q2	–	Sell	-14,182	Closed	-$22K	–	4060
2024 Q1	$22K	Buy	+14,182	New	+$21.1K	﹤0.01%	3956

Other funds holding CADL

Tanager Wealth Management Goring On Thames, United Kingdom $1.2B AUM 12% 1-Year Est. Return

Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return

Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return

HB Wealth Management Atlanta, Georgia $19.5B AUM 16.96% 1-Year Est. Return

Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return

China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return

ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return

Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $57B AUM 43.56% 1-Year Est. Return

Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return

Commonwealth Equity Services's CADL Position: Q3 2026 in Review

Commonwealth Equity Services reduced its Candel Therapeutics (CADL) stake by 0.28% in Q3 2026, selling an estimated $3.59K and leaving 115,551 shares worth $1.21M. The position accounts for ﹤0.01% of the portfolio, ranked #2512.

Commonwealth Equity Services first reported a position in CADL in Q1 2024 and has held it in 9 quarters since. 23 funds tracked by Wall St. Rank hold CADL as of Q3 2026.

Commonwealth Equity Services held 115,551 shares of Candel Therapeutics worth $1.21M as of Q3 2026.
Commonwealth Equity Services sold 324 Candel Therapeutics shares in Q3 2026, an estimated $3.59K.
Candel Therapeutics made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q3 2026, its #2512 holding.
Commonwealth Equity Services first reported a position in Candel Therapeutics in Q1 2024 and has held it in 9 quarters since.
23 funds tracked by Wall St. Rank held Candel Therapeutics as of Q3 2026.

Based on Commonwealth Equity Services's 13F filing for Q3 2026, filed 2 Nov 2026.